Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.
Related Research units
Abstract
To test whether the rates of in-hospital mortality, complications, and transfusions are higher in patients treated with cytoreductive nephrectomy (CNT) for metastatic renal cell carcinoma (mRCC) relative to patients treated with nephrectomy (NT) for non-mRCC.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 10 |
| ISSN | 1068-9265 |
| Publication status | Published - 2011 |
| pubmed | 21499808 |
|---|
